To investigate the potential therapeutic impacts of PDE-5 inhibitor, VAR, in alleviating the burden of toxic agglomerates; a preliminary study was firstly conducted to determine the VAR optimal therapeutic dose in our AD model. The gene discussed is PDE5A; the disease is Alzheimer disease.